With the strengthening of the technical strength of our interventional ward, the development of new technologies and the support of our gynecologic and obstetric colleagues, minimally invasive interventional treatment for obstetric and gynecologic diseases has enabled more and more female patients to achieve uterine preservation and relief of pain. Recently, Dr. Lei Yu and Dr. Xiaoyu Yi, attending physicians of oncology interventional ward, followed up female patients who underwent bilateral uterine artery interventional embolization for adenomyosis and uterine fibroids, and the results showed that the patients could achieve the effects of improving anemia, relieving dysmenorrhea, increasing conception rate and normalizing menstrual flow within a short period of time after the operation. She actively promoted and recommended the treatment to her friends. Adenomyosis, also known as intrinsic endometriosis, is a benign lesion caused by the invasion of the basal layer of the endometrium into the myometrium, and occurs mainly in menstruating women over 30 years of age. Adenomyosis is also known as chronic cancer because it produces symptoms such as dysmenorrhea, increased menstruation, and infertility that often cause great pain to patients. Traditionally, hormonal therapy or surgery is used, but the side effects of hormonal therapy and the recurrence of the disease after stopping the medication, as well as the need to remove the uterus during surgery, make it difficult for some patients, especially those with fertility requirements, to accept. Interventional treatment does not require any surgery, but only requires a puncture needle to penetrate the femoral artery to reach the uterine arteries bilaterally and use a special embolic agent to embolize the branches and trunk of the uterine arteries, so that the necrosis of the lesions in the uterus can be absorbed, shrink or even disappear. The mechanism of action is as follows: 1. After the lesion shrinks, the irritating substances released from the lesion, such as prostaglandins, which can cause uterine contraction, are reduced, thus improving the symptoms of dysmenorrhea. As the lesion shrinks, the uterus becomes softer, the volume of the uterus and the area of the uterine cavity are reduced accordingly, and the menstrual flow is reduced or returned to normal. 2. Normal endometrium can regrow and resume normal function through collateral circulation after embolization, while ectopic endometrium has irreversible necrosis and cannot regrow due to the lack of support from the basal layer. 3. The necrosis of ectopic endometrium reduces the amount of local estrogen and its receptors, interrupting the vicious cycle of adenomyosis spreading and reducing the possibility of recurrence. The main indications for interventional treatment of adenomyosis: those who have typical clinical symptoms and signs, with clear clinical diagnosis by ultrasound, CT, MRI, etc. Those who are unable to continue drug treatment because of ineffective drug therapy or high side effects. Those who have contraindications to surgery or refuse surgery and require preservation of the uterus and reproductive function. Those who have a history of pelvic surgery or pelvic adhesions and estimated difficulties in surgery. Those who cannot tolerate surgery due to frailty or serious medical diseases such as diabetes. Interventional treatment of adenomyosis and fibroids has the advantages of less trauma, less pain, rapid symptom relief, less recurrence, less complications, etc. It can preserve the uterus and fertility, and plays an important role in maintaining the endocrine function and physical and mental health of patients. The promotion and application of this technology has opened up an effective treatment pathway for patients with the above-mentioned diseases. At the same time, interventional treatment also plays a unique advantage in postpartum hemorrhage, malignant uterine tumor, tubal blockage, placenta praevia and ectopic pregnancy, etc. We welcome all women to visit and consult us.